Cargando…

Advances in COVID-19 mRNA vaccine development

To date, the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has determined 399,600,607 cases and 5,757,562 deaths worldwide. COVID-19 is a serious threat to human health globally. The World Health Organization (WHO) has declared COVID-19 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Enyue, Liu, Xiaohui, Li, Miao, Zhang, Zelun, Song, Lifang, Zhu, Baiyu, Wu, Xiaohong, Liu, Jingjing, Zhao, Danhua, Li, Yuhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940982/ https://www.ncbi.nlm.nih.gov/pubmed/35322018 http://dx.doi.org/10.1038/s41392-022-00950-y

Ejemplares similares

Construction and immunogenicity of an mRNA vaccine against chikungunya virus
por: Liu, Jingjing, et al.
Publicado: (2023)

An mRNA vaccine against rabies provides strong and durable protection in mice
por: Li, Miao, et al.
Publicado: (2023)

Investigation of immune response induction by Japanese encephalitis live‐attenuated and chimeric vaccines in mice
por: Fang, Enyue, et al.
Publicado: (2022)

Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice
por: Li, Wenjuan, et al.
Publicado: (2021)

Construction of a Dengue NanoLuc Reporter Virus for In Vivo Live Imaging in Mice
por: Fang, Enyue, et al.
Publicado: (2022)

NS1 Protein N-Linked Glycosylation Site Affects the Virulence and Pathogenesis of Dengue Virus
por: Fang, Enyue, et al.
Publicado: (2023)

Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice
por: Li, Xingxing, et al.
Publicado: (2023)

Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice
por: Li, Xingxing, et al.
Publicado: (2022)

An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs
por: Li, Jianglong, et al.
Publicado: (2022)

Advances in mRNA vaccines
por: Li, Mengyun, et al.
Publicado: (2022)

Research Advances on the Stability of mRNA Vaccines
por: Cheng, Feiran, et al.
Publicado: (2023)

Advances of mRNA vaccines for COVID-19: A new prophylactic revolution begins
por: Weng, Yuhua, et al.
Publicado: (2021)

Advances in mRNA Vaccines for Infectious Diseases
por: Zhang, Cuiling, et al.
Publicado: (2019)

The advances of adjuvants in mRNA vaccines
por: Xie, Chunyuan, et al.
Publicado: (2023)

Validation of an HPLC-CAD Method for Determination of Lipid Content in LNP-Encapsulated COVID-19 mRNA Vaccines
por: Yu, Xiaojuan, et al.
Publicado: (2023)

Advances in mRNA-Based Cancer Vaccines
por: Ni, Ling
Publicado: (2023)

mRNA vaccine in cancer therapy: Current advance and future outlook
por: Li, Youhuai, et al.
Publicado: (2023)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

mRNA vaccines for COVID-19 and diverse diseases
por: Hussain, Abid, et al.
Publicado: (2022)

mRNA cancer vaccines: Advances, trends and challenges
por: He, Qing, et al.
Publicado: (2022)

Recent Advancement in mRNA Vaccine Development and Applications
por: Al Fayez, Nojoud, et al.
Publicado: (2023)

Advances in mRNA and other vaccines against MERS-CoV
por: Tai, Wanbo, et al.
Publicado: (2022)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
por: Kang, Diana D., et al.
Publicado: (2023)

Advancing mRNA technologies for therapies and vaccines: An African context
por: Kairuz, Dylan, et al.
Publicado: (2022)

Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV
por: Wang, Qian, et al.
Publicado: (2022)

The global mRNA vaccine patent landscape
por: Li, Mengyao, et al.
Publicado: (2022)

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
por: Wang, Bolin, et al.
Publicado: (2023)

Amplifying mRNA vaccines: potential versatile magicians for oncotherapy
por: Hu, Chaoying, et al.
Publicado: (2023)

Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines
por: Guo, Xiao, et al.
Publicado: (2023)

Dangers of mRNA vaccines
por: Ali, Tahoora, et al.
Publicado: (2021)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

Development and Delivery Systems of mRNA Vaccines
por: Liang, Yongjun, et al.
Publicado: (2021)

Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules
por: Zhang, Jingjing, et al.
Publicado: (2023)

Clinical advances and ongoing trials of mRNA vaccines for cancer treatment
por: Lorentzen, Cathrine Lund, et al.
Publicado: (2022)

Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
por: Yuan, Yuan, et al.
Publicado: (2023)

Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines
por: Swetha, K., et al.
Publicado: (2023)

mRNA vaccines: the most recent clinical applications of synthetic mRNA
por: Kwon, Suji, et al.
Publicado: (2022)

Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_im22pe7lcn6vecls0f1pa8pa8c